Capitolis Advisors LLC Mckesson Corp Transaction History

Capitolis Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$244.61 - $310.48 $19.3 Million - $24.5 Million	-78,815 Reduced 93.71%	5,286 $1.62 Million
Q4 2021 Feb 11, 2022	BUY	$198.21 - $248.9 $11 Million - $13.8 Million	55,286 Added 191.87%	84,101 $20.9 Million
Q3 2021 Nov 12, 2021	BUY	$188.42 - $208.66 $4.69 Million - $5.19 Million	24,888 Added 633.77%	28,815 $5.79 Million
Q1 2021 May 13, 2021	SELL	$169.52 - $196.53 $936,258 - $1.09 Million	-5,523 Reduced 58.44%	3,927 $766,000
Q4 2020 May 07, 2021	BUY	$143.79 - $183.66 $1.36 Million - $1.74 Million	9,450 New	9,450 $1.64 Million

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.